Virkningen af Revasc som antikoagulerende middel er undersøgt i fire undersøgelser, hvori der deltog 1 621 patienter, som fik Revasc.
The effectiveness of Revasc as an anticoagulant has been studied in four studies involving 1,621 patients who received Revasc.